Evidence map›Paper›PMID 20980482›Full record

ArticleClinical and vaccine immunology : CVI2010

Escherichia coli K88ac fimbriae expressing heat-labile and heat-stable (STa) toxin epitopes elicit antibodies that neutralize cholera toxin and STa toxin and inhibit adherence of K88ac fimbrial E. coli.

Chengxian Zhang, Weiping Zhang

Open access · diamondAbstract read
In one paragraph

Article in Clinical and vaccine immunology : CVI, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
2.2field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 38 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Chengxian ZhangVeterinary and Biomedical Sciences Department, The Center for Infectious Disease Research and Vaccinology, South Dakota State University, Box 2157, North Campus Drive, Brookings, SD 57006, USA.
Weiping Zhang
South Dakota State University · US

Funding

Development of an additive model to study the significance of heat-labile and heaR03AI068766 · NIAID · SOUTH DAKOTA STATE UNIVERSITY · PI ZHANG, WEIPING · 2007 to 2008
$143k
NIAID NIH HHS AI068766NIAID NIH HHS R03 AI068766
6 · The paper itself

Abstract

Enterotoxigenic Escherichia coli (ETEC) strains are a major cause of diarrheal disease in humans and animals. Bacterial adhesins and heat-labile (LT) and heat-stable (ST) enterotoxins are the virulence determinants in ETEC diarrhea. It is believed that vaccines inducing anti-adhesin immunity to inhibit bacterial adherence and anti-toxin immunity to eliminate toxin activity would provide broad-spectrum protection against ETEC. In this study, an ETEC fimbrial adhesin was used as a platform to express LT and STa for adhesin-toxin fusion antigens to induce anti-toxin and anti-adhesin immunity. An epitope from the B subunit of LT toxin (LTP1, (8)LCSEYRNTQIYTIN(21)) and an STa toxoid epitope ((5)CCELCCNPQCAGCY(18)) were embedded in the FaeG major subunit of E. coli K88ac fimbriae. Constructed K88ac-toxin chimeric fimbriae were harvested and used for rabbit immunization. Immunized rabbits developed anti-K88ac, anti-LT, and anti-STa antibodies. Moreover, induced antibodies not only inhibited adherence of K88ac fimbrial E. coli to porcine small intestinal enterocytes but also neutralized cholera toxin and STa toxin. Data from this study demonstrated that K88ac fimbriae expressing LT and STa epitope antigens elicited neutralizing anti-toxin antibodies and anti-adhesin antibodies and suggested that E. coli fimbriae could serve as a platform for the development of broad-spectrum vaccines against ETEC.

Indexed as

AnimalsAntibodies, BacterialAntibodies, NeutralizingAntigens, BacterialBacterial AdhesionBacterial ToxinsCells, CulturedCholera ToxinEnterotoxigenic Escherichia coliEnterotoxinsEpithelial CellsEpitopesEscherichia coli InfectionsEscherichia coli ProteinsEscherichia coli VaccinesFimbriae ProteinsAntibodies, BacterialAntibodies, NeutralizingAntigens, BacterialBacterial ToxinsCholera ToxinEnterotoxinsEpitopesEscherichia coli ProteinsEscherichia coli VaccinesFimbriae Proteinsheat-labile enterotoxin, E coliheat stable toxin (E coli)K88 antigen, E coliVaccines, Synthetic

Identifiers

PMID20980482
PMCPMC3008177
OpenAlexW2127929866

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.